It is likely due to that HNF-4a has much higher binding affinity for its responsive element in HBV core promoter than that in enhancer I/X promoter

ion was taken as a measure of decidualization. PRL secretion by nondecidualized HESC was undetectable. PRL secretion by decidualized HESC was 3.10661.362 mIU/mg with a range of 0.47146.676 mIU/mg. Decidualized HESC secreting,1.5 and.5 mIU/mg PRL were excluded from further experiments to standardise the level of decidualization across cultures. EVT treatment with HESC CM EVT cultured in a 6 well plate on top of matrigel were treated overnight with 500 ml low-serum media or non-decidualized or decidualized HESC CM. As a control, each of treatments was also incubated for 16 h in wells coated with Matrigel. These controls were also subjected to the proteomics analysis detailed below to allow exclusion of proteins expressed by the decidua. The EVT/Matrigel CM was centrifuged at 1606g to remove cell debris and stored at 280uC. Cell lysates were collected and protein quantified as described above. Conditioned media fractionation. Proteins in the CM with a molecular weight of,30 kDa were fractionated from the remaining media using size-exclusion affinity hydrogel nanoparticles as previously described. Briefly, total protein was precipitated from the CM by incubation in 100% acetone at 220uC overnight. The protein pellet was resuspended in 10 mM 2- ethanesulfonic acid, pH 6 before addition of 3 mg SEAN and incubation at RT for 20 min followed by centrifugation to pellet the SEAN. After washes, the fractionated proteins were eluted from the SEAN and concentrated in a centrifugal vacuum concentrator. Protein identification. Proteins eluted from the SEAN were reduced with 10 mM DTT at 56uC for 30 minutes and then thiol groups alkylated with 50 mM iodoacetic acid 30 minutes at RT. Proteins were digested overnight at 37uC with 375 ng trypsin. The extracted peptide solution were then concentrated to approximately 10 ml by centrifugal lyophilisation using a SpeedVac AES 1010. Extracted peptides were then injected and fractionated by nanoflow reversed-phase liquid chromatography on a nano LC system using a nanoAcquity C18 150 mm60.15 mm I.D. column MedChemExpress Chlorphenoxamine developed with a linear 60-min gradient with a flow rate of 0.5 ml/min at 45uC from 100% solvent A to 100% solvent B 40% Milli-Q water). The nano HPLC was coupled on-line to PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/22181854 an LTQOrbitrap mass spectrometer equipped with a nanoelectrospray ion source for automated MS/MS. Data dependent MS analysis was performed by acquiring one FTMS scan followed by MS2 on the top five most intense ions. Dynamic exclusion was enabled at repeat count 1, exclusion list size 500, exclusion duration 180 s, and exclusion mass width+/21.5 m/z. Collision induced dissociation was performed by setting the ion isolation width at 2 m/z, normalized collision energy at 35%, activation Q at 0.25 and an activation time at 30 ms. Spectra were exported in mascot generic file format and analyzed using the Mascot search engine. Standard search parameters included a peptide mass tolerance of 1.5 Da, peptide fragment tolerance of 0.8 Da, peptide charge of +2 or +3 and up to 1 missed cleavage allowed. Identified proteins were cross-checked between the 6 groups. Proteins identified in the media alone control were identified as proteins in the media or expressed by matrigel and excluded from all other groups. Proteins identified in the ND or D CM controls were identified as proteins expressed by HESC and excluded from all other groups. Proteins identified in EVT treated with media alone were identified as proteins expressed by EVT in vitro regardles